Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report)’s stock price traded up 0.7% during mid-day trading on Tuesday . The company traded as high as $42.90 and last traded at $42.20. 21,958 shares changed hands during trading, a decline of 19% from the average session volume of 27,262 shares. The stock had previously closed at $41.92.
Virtus LifeSci Biotech Clinical Trials ETF Stock Up 0.7%
The business has a 50 day moving average price of $39.67 and a two-hundred day moving average price of $31.23.
About Virtus LifeSci Biotech Clinical Trials ETF
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
See Also
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
